229 related articles for article (PubMed ID: 29194599)
21. The Synthetic Cannabinoids Phenomenon.
Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
[TBL] [Abstract][Full Text] [Related]
22. Synthetic cannabinoid isomers characterization by MALDI-MS
Kernalléguen A; Enjalbal C; Alvarez JC; Belgacem O; Léonetti G; Lafitte D; Pélissier-Alicot AL
Anal Chim Acta; 2018 Dec; 1041():87-93. PubMed ID: 30340694
[TBL] [Abstract][Full Text] [Related]
23. Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids?
Hess C; Stockhausen S; Kernbach-Wighton G; Madea B
Forensic Sci Int; 2015 Dec; 257():e6-e11. PubMed ID: 26363623
[TBL] [Abstract][Full Text] [Related]
24. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS.
Oiestad EL; Johansen U; Christophersen AS; Karinen R
Bioanalysis; 2013 Sep; 5(18):2257-68. PubMed ID: 24053241
[TBL] [Abstract][Full Text] [Related]
25. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
Shanks KG; Dahn T; Behonick G; Terrell A
J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
[TBL] [Abstract][Full Text] [Related]
26. Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances.
Reid MJ; Derry L; Thomas KV
Drug Test Anal; 2014; 6(1-2):72-9. PubMed ID: 23460377
[TBL] [Abstract][Full Text] [Related]
27. Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review.
de Oliveira MC; Vides MC; Lassi DLS; Torales J; Ventriglio A; Bombana HS; Leyton V; Périco CA; Negrão AB; Malbergier A; Castaldelli-Maia JM
Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508922
[TBL] [Abstract][Full Text] [Related]
28. Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption.
Kovács K; Kereszty É; Berkecz R; Tiszlavicz L; Sija É; Körmöczi T; Jenei N; Révész-Schmehl H; Institóris L
J Forensic Leg Med; 2019 Jul; 65():92-100. PubMed ID: 31128567
[TBL] [Abstract][Full Text] [Related]
29. Case reports of synthetic cannabinoid XLR-11 associated fatalities.
Shanks KG; Winston D; Heidingsfelder J; Behonick G
Forensic Sci Int; 2015 Jul; 252():e6-9. PubMed ID: 25979131
[TBL] [Abstract][Full Text] [Related]
30. The role of ultra high performance liquid chromatography with time of flight detection for the identification of synthetic cannabinoids in seized drugs.
Marginean I; Rowe WF; Lurie IS
Forensic Sci Int; 2015 Apr; 249():83-91. PubMed ID: 25679986
[TBL] [Abstract][Full Text] [Related]
31. Identification of the Synthetic Cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in Plant Material and Quantification in Post-Mortem Blood Samples.
Yeter O
J Anal Toxicol; 2017 Nov; 41(9):720-728. PubMed ID: 28977413
[TBL] [Abstract][Full Text] [Related]
32. Atrial fibrillation following synthetic cannabinoid abuse.
Efe TH; Felekoglu MA; Çimen T; Doğan M
Turk Kardiyol Dern Ars; 2017 Jun; 45(4):362-364. PubMed ID: 28595208
[TBL] [Abstract][Full Text] [Related]
33. Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.
Alves VL; Gonçalves JL; Aguiar J; Caldeira MJ; Teixeira HM; Câmara JS
Anal Bioanal Chem; 2021 Mar; 413(8):2257-2273. PubMed ID: 33575815
[TBL] [Abstract][Full Text] [Related]
34. Ischemic stroke associated with the use of a synthetic cannabinoid (spice).
Moeller S; Lücke C; Struffert T; Schwarze B; Gerner ST; Schwab S; Köhrmann M; Machold K; Philipsen A; Müller HH
Asian J Psychiatr; 2017 Feb; 25():127-130. PubMed ID: 28262132
[TBL] [Abstract][Full Text] [Related]
35. Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers.
Salomone A; Luciano C; Di Corcia D; Gerace E; Vincenti M
Drug Test Anal; 2014; 6(1-2):126-34. PubMed ID: 24115381
[TBL] [Abstract][Full Text] [Related]
36. Synthetic cannabinoid drug use as a cause or contributory cause of death.
Labay LM; Caruso JL; Gilson TP; Phipps RJ; Knight LD; Lemos NP; McIntyre IM; Stoppacher R; Tormos LM; Wiens AL; Williams E; Logan BK
Forensic Sci Int; 2016 Mar; 260():31-39. PubMed ID: 26795398
[TBL] [Abstract][Full Text] [Related]
37. Synthetic cannabinoid intoxication: a case series and review.
Harris CR; Brown A
J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
[TBL] [Abstract][Full Text] [Related]
38. Discrimination between closely related synthetic cannabinoids by GC-Cold-EI-MS.
Smolianitski-Fabian E; Cohen E; Dronova M; Voloshenko-Rossin A; Lev O
Drug Test Anal; 2018 Mar; 10(3):474-487. PubMed ID: 28688175
[TBL] [Abstract][Full Text] [Related]
39. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids.
Spinelli E; Barnes AJ; Young S; Castaneto MS; Martin TM; Klette KL; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):467-74. PubMed ID: 25167963
[TBL] [Abstract][Full Text] [Related]
40. Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids.
Karinen R; Tuv SS; Øiestad EL; Vindenes V
Forensic Sci Int; 2015 Jan; 246():98-103. PubMed ID: 25485949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
